Sai Parenteral IPO: Issue details, key dates, subscription status—What investors should know

Sai Parenteral IPO: Sai Parenteral's Limited, the pharmaceutical formulations company, launched its initial public offering (IPO) of Rs 408.79 crore on March 24, 2026. The public offer is a mix of fresh issue and offer for sale (OFS) of shares. As of 12:35 pm, the public offer was subscribed to 2 per cent, according to the provisional exchange data.

Sai Parenteral's IPO subscription status

As of 1:30 pm, the IPO had received subdued demand from investors, with bids for 1.65 lakh shares out of the net offer, resulting in a 0.02 times the overall subscription.

Add Zee Business as a Preferred Source

• The Qualified Institutional Buyers (QIBs) portion is yet to receive a bid for its 21.12 lakh shares reserved.
• The Non-Institutional Investors (NIIs) category has booked 0.06 times so far, with bids for 96,140 shares out of the 16.22 lakh reserved.
• Retail Individual Investors (RIIs) have booked 0.02 times the allotted shares so far, with 69,654 shares bid out of the 37.86 lakh shares allotted.

Sai Parenteral IPO issue details

The IPO is a book-built issue of Rs 408.79 crore, consisting of a mix of fresh issue of 0.73 crore shares and an offer-for-sale (OFS) of 0.32 crore shares.

Sai Parenteral IPO key dates

Subscription date: The IPO will remain open for public bidding till March 27, 2026.

Allotment date: The basis of allotment of the IPO shares is expected to be finalised on March 30, 2026.

Listing date: The IPO stock is expected to list on both the stock exchanges (BSE and NSE) on April 2, 2026.

Sai Parenteral IPO lead manager and registrar details

According to the company's red-herring prospectus (RHP), Arihant Capital Markets Ltd is the book-running lead manager, while Bigshare Services Pvt Ltd is the registrar of the issue.

Sai Parenteral IPO price band & lot size

Sai Parenteral has priced its public offer at Rs 372 to Rs 392 per equity share, giving the company a valuation of around Rs 1,731.83 crore.

Investors could bid in a lot size of 38 shares, with the minimum amount of investment required by a retail investor being Rs 14,896 (based on the upper end of the price band).

Sai Parenteral's Limited Company Profile

Founded in 2001, Sai Parenterals Ltd. is a pharmaceutical company engaged in the development, manufacturing, and commercialisation of a wide range of formulations.

The business is structured across two key verticals: branded generic formulations and Contract Development and Manufacturing Organisation (CDMO) services, catering to both domestic and global markets.

Its portfolio covers diverse therapeutic segments such as cardiovascular care, neuropsychiatry, diabetes management, respiratory treatments, anti-infectives, gastrointestinal care, dermatology, pain management, and vitamins, minerals, and supplements (VMS). The company offers products in multiple dosage formats, including injectables, tablets, capsules, oral liquids, and topical formulations like ointments.